EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Hepatology

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2014.03.033PMID 24704591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholangiocarcinoma.

  2014cited by this paper
• Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

  2013cited by this paper
• Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

  2013cited by this paper
• Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells

  2012cited by this paper
• Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

  2012cited by this paper
• EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?

  2012cited by this paper
• EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

  2012cited by this paper
• Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma

  2012cited by this paper
• Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.

  2012cited by this paper
• Nuclear expression of S100A4 calcium‐binding protein increases cholangiocarcinoma invasiveness and metastasization

  2011cited by this paper
• FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion

  2011cited by this paper
• Expanding roles of ZEB factors in tumorigenesis and tumor progression.

  2011cited by this paper
• Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag Proteomics*

  2010cited by this paper
• Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

  2010cited by this paper
• Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma.

  2010cited by this paper
• Epithelial-mesenchymal transition in the liver.

  2010cited by this paper
• Zeb1‐mediated T‐cadherin repression increases the invasive potential of gallbladder cancer

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas

  2009cited by this paper
• Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.

  2008cited by this paper
• Reorganisation of the dendritic actin network during cancer cell migration and invasion.

  2008cited by this paper
• Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

  2008cited by this paper
• EGFR and HER2 expression in advanced biliary tract cancer.

  2008cited by this paper
• Cortactin in tumor invasiveness.

  2008cited by this paper
• Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma

  2007cited by this paper
• The role of epithelial-mesenchymal transition in cancer pathology.

  2007cited by this paper
• The complexity of targeting EGFR signalling in cancer: from expression to turnover.

  2006cited by this paper
• Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.

  2006cited by this paper
• A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.

  2006cited by this paper
• Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1.

  2005cited by this paper
• Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells.

  2004cited by this paper
• FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly

  2004cited by this paper
• Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

  2003cited by this paper
• Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility.

  2002cited by this paper
• Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.

  2001cited by this paper
• Expression of Epidermal Growth Factor and Its Receptor in Cirrhotic Liver Disease

  2000cited by this paper

• PTEN-AKT2 Regulates Mixed Lineage Liver Cancer Development and Sensitizes Cancer Cells to TGFβ Treatment

  2026cites this paper
• Oncogenesis in cholangiocarcinoma.

  2026cites this paper
• Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential

  2025cites this paper
• Loss of aquaporin-1 in tumor cells fosters intrahepatic cholangiocarcinoma progression.

  2025cites this paper
• Metastatic microenvironment of extrahepatic cholangiocarcinoma.

  2025cites this paper
• Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms

  2025cites this paper
• EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy

  2025cites this paper
• ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma

  2025cites this paper
• DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation

  2025cites this paper
• The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies

  2025cites this paper
• Heteronemin suppresses EGF‑induced proliferation through the PI3K/PD‑L1 signaling pathways in cholangiocarcinoma.

  2025cites this paper
• Opioid System and Epithelial–Mesenchymal Transition

  2025cites this paper
• Integrative Spatial Transcriptomics and Experimental Validation Reveal UBC-Mediated EMT Associated with Immune Evasion in Hepatocellular Carcinoma

  2025cites this paper
• Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway

  2024cites this paper
• Wnt/β-Catenin Signaling in Liver Pathobiology.

  2024cites this paper
• OTUD6B promotes cholangiocarcinoma growth by regulating STAT3 phosphorylation through deubiquitination of PTK2

  2024cites this paper
• Cholangiocyte ciliary defects induce sustained epidermal growth factor receptor signaling

  2024influential citation
• Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‑mesenchymal transition in intrahepatic cholangiocarcinoma cells

  2024cites this paper
• The role of extracellular vesicles in cholangiocarcinoma tumor microenvironment

  2024cites this paper
• Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children

  2023cites this paper
• Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)

  2023cites this paper
• Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma

  2023cites this paper
• Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells

  2023cites this paper
• Cholangiokines: undervalued modulators in the hepatic microenvironment

  2023cites this paper
• Heterogeneity, crosstalk and targeting of cancer associated fibroblasts in cholangiocarcinoma.

  2023cites this paper
• Direct Conversion of Human Endothelial Cells Into Liver Cancer‐Forming Cells Using Nonintegrative Episomal Vectors

  2022cites this paper
• Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor

  2022cites this paper
• Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study

  2022influential citation
• Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.

  2022cites this paper
• Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking

  2022cites this paper
• Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology

  2022cites this paper
• NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis

  2022cites this paper
• The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling

  2022cites this paper
• Vitamin D3 alleviates cigarette smoke extract-mediated epithelial-mesenchymal transition and fibrogenesis by upregulating CC16 expression in bronchial epithelial cells

  2022cites this paper
• Insights into the role of STAT3 in intrahepatic cholangiocarcinoma

  2022cites this paper
• YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation

  2022cites this paper
• The Cross-Talk Between EGFR and E-Cadherin

  2022cites this paper
• Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer

  2021cites this paper
• Cholangiocarcinoma

  2021cites this paper
• Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic wound healing.

  2021cites this paper
• Biliary cancer: gateway to comprehensive molecular profiling.

  2021cites this paper
• Shikonin Inhibits Cholangiocarcinoma Cell Line QBC939 by Regulating Apoptosis, Proliferation, and Invasion

  2021cites this paper
• Role of microRNAs in Lung Carcinogenesis Induced by Asbestos

  2021cites this paper
• Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic

  2021cites this paper
• Involvement of microRNA in Solid Cancer: Role and Regulatory Mechanisms

  2021cites this paper
• Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies

  2021cites this paper
• Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells

  2021cites this paper
• Zinc Finger E‐Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling

  2021cites this paper
• Expression of EMT-Related Factors in Intrahepatic Cholangiolithiasis Associated Cholangiocarcinoma and Its Clinical Significance

  2021cites this paper
• Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

  2021cites this paper
• Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma

  2021cites this paper
• CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway

  2021cites this paper
• ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications

  2020cites this paper
• SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.

  2020cites this paper
• Regorafenib, an investigational agent for the treatment of cholangiocarcinoma

  2020cites this paper
• Cholangiocarcinoma 2020: the next horizon in mechanisms and management

  2020cites this paper
• Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma

  2020cites this paper
• Anticancer Effect of Radix Astragali on Cholangiocarcinoma In Vitro and Its Mechanism via Network Pharmacology

  2020cites this paper
• Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model

  2020cites this paper
• Advances in Understanding TKS4 and TKS5: Molecular Scaffolds Regulating Cellular Processes from Podosome and Invadopodium Formation to Differentiation and Tissue Homeostasis

  2020cites this paper
• Loss of CPAP expression promotes sustained EGFR signaling and Epithelial-Mesenchymal Transition in oral cancer cells

  2020cites this paper
• Absence of the Tks4 Scaffold Protein Induces Epithelial-Mesenchymal Transition-Like Changes in Human Colon Cancer Cells

  2019cites this paper
• Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway.

  2019cites this paper
• Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma

  2019cites this paper
• Aberrant N-cadherin expression in cancer.

  2019cites this paper
• Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway

  2019cites this paper
• Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment

  2019cites this paper
• Ten years of research on the role of BveS/ POPDC1 in human disease: a review

  2019cites this paper
• Ten years of research on the role of BveS/ POPDC1 in human disease: a review

  2019cites this paper
• MicroRNA in Lung Cancer Metastasis

  2019cites this paper
• The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression

  2019cites this paper
• Functional Diversity of p53 in Human and Wild Animals

  2019cites this paper
• Ten years of research on the role of BVES/ POPDC1 in human disease: a review

  2019cites this paper
• Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance

  2019cites this paper
• Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells

  2019cites this paper
• Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axis.

  2019cites this paper
• β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer

  2019cites this paper
• Opportunities and challenges of co-targeting epidermal growth factor receptor and autophagy signaling in non-small cell lung cancer.

  2019cites this paper
• Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma

  2018cites this paper
• Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer

  2018cites this paper
• Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology

  2018influential citation
• The role of tumour microenvironment: a new vision for cholangiocarcinoma

  2018cites this paper
• Extracellular Vesicles in Hepatobiliary Malignancies

  2018cites this paper
• Precision medicine in cholangiocarcinoma.

  2018cites this paper
• Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival.

  2018cites this paper
• IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma

  2018cites this paper
• Forkhead box O proteins: Crucial regulators of cancer EMT.

  2018cites this paper
• Pigments from Filamentous Ascomycetes for Combination Therapy.

  2018cites this paper
• Molecular mechanisms of cholangiocarcinoma progression: emphasizing the role of tumor-stroma interactions

  2018cites this paper
• Neuropilin‐1 regulated by miR‐320 contributes to the growth and metastasis of cholangiocarcinoma cells

  2018cites this paper
• Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis

  2018cites this paper
• Emerging molecular target antagonists for the treatment of biliary tract cancer

  2018cites this paper
• The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma

  2018cites this paper
• PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells.

  2018cites this paper
• EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells.

  2017cites this paper
• Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.

  2017cites this paper
• Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation.

  2017cites this paper
• Ceruloplasmin as a prognostic marker in patients with bile duct cancer

  2017cites this paper
• Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy.

  2017cites this paper
• Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma

  2017cites this paper